Suk‐Jo Kang

2.4k citations
44 papers · 1.9k indexed · h-index 22
Topics
Immune Response and Inflammation (14 papers)Immune Cell Function and Interaction (13 papers)T-cell and B-cell Immunology (10 papers)

In The Last Decade

Suk‐Jo Kang

42 papers receiving 1.8k citations

Peers

Suk‐Jo Kang
Comparison fields: 5 of 127
  • Immunology 1.1k
  • Molecular Biology 468
  • Oncology 229
  • Biomedical Engineering 220
  • Atomic and Molecular Physics, and Optics 179
Replace Aki Manninen with:
Aki Manninen Finland
Debasish Sen United States
Renaud Poincloux France
Ann P. Wheeler United Kingdom
Dominic Waithe United Kingdom
Yaming Jiu China
Susan K. Pierce United States
Sandrine Lécart France
Ed Luther United States
Kenta Terai Japan
Suk‐Jo Kang relative to Aki Manninen Finland Aki Manninen's profile →
Citations per field
00.5×1.5×2.2×
Aki Manninen · 1×
Citations per year

Countries citing papers authored by Suk‐Jo Kang

Since Specialization
Citations

This map shows the geographic impact of Suk‐Jo Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suk‐Jo Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suk‐Jo Kang more than expected).

Fields of papers citing papers by Suk‐Jo Kang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suk‐Jo Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suk‐Jo Kang. The network helps show where Suk‐Jo Kang may publish in the future.

Co-authorship network of co-authors of Suk‐Jo Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Suk‐Jo Kang. A scholar is included among the top collaborators of Suk‐Jo Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suk‐Jo Kang. Suk‐Jo Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 4
3 0
4 6
5 5
6 11
7 49
8 130
9 35
10 135
11 54
12 91
13 25
14 4
15 75
16 10
17 142
18 91
19 55
20 170

About Suk‐Jo Kang

Suk‐Jo Kang is a scholar working on Immunology, Biophysics and Physiology, having authored 44 papers that have together received 1.9k indexed citations. Recurring topics across this work include Immune Response and Inflammation (14 papers), Immune Cell Function and Interaction (13 papers) and T-cell and B-cell Immunology (10 papers). The work is most often cited by research in Immunology (1.1k citations), Biophysics (136 citations) and Media Technology (80 citations). Suk‐Jo Kang has collaborated with scholars based in South Korea, United States and United Kingdom. Frequent co-authors include Peter Cresswell, Richard M. Locksley, Hong-Erh Liang, Minhyeok Kim, Boris Reizis, YoungJu Jo, YongKeun Park, R. Lee Reinhardt, Weiming Yuan and Bong Geun. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026